Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
04 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250604599467/en/U.S.-FDA-Grants-Platform-Technology-Designation-to-the-Viral-Vector-Used-in-SRP-9003-Sareptas-Investigational-Gene-Therapy-for-the-Treatment-of-Limb-Girdle-Muscular-Dystrophy-Type-2ER4
21 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250521736806/en/Sarepta-Provides-Update-on-UK-Dosing-in-ENVISION-Study-of-ELEVIDYS-for-the-treatment-of-Duchenne-Muscular-Dystrophy
16 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250516650167/en/Sarepta-Therapeutics-Shares-New-Protein-Expression-and-Safety-Results-from-ENDEAVOR-in-Participants-2-Years-Old-at-Time-of-Treatment
16 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250516672196/en/Sarepta-Therapeutics-Presents-Data-at-the-American-Society-of-Gene-Cell-Therapy-Conference-Including-Statistically-Significant-Functional-Outcomes-for-8--and-9-Year-Old-Patients-in-New-Data-Analysis-of-EMBARK-Part-2
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513283552/en/Sarepta-Therapeutics-Announces-Approval-in-Japan-of-ELEVIDYS-a-Gene-Therapy-to-Treat-Duchenne-Muscular-Dystrophy
08 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/sarepta-tries-quell-concerns-over-dmd-gene-therapy-elevidys-patients-pause-treatment-after
ABOUT THIS PAGE
Sarepta Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of SRP-2001 DRUG SUBSTANCE bulk with DMF offered by Sarepta Therapeutics
Find a price of AVI 4126 bulk offered by Sarepta Therapeutics